VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹1.24 Cr | ₹0.62 Cr | ₹0.67 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VALIANT LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹1.24 Cr |
| Mar2024 | ₹0.62 Cr |
| Mar2023 | ₹0.67 Cr |
How is Deferred Tax Assets / Liabilities of VALIANT LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.24 Cr | 100.97 | |
| Mar2024 | ₹0.62 Cr | -7.21 | |
| Mar2023 | ₹0.67 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹320.8 Cr | -4.5% | 1.2% | -38.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -4.5% |
1.2% |
-38.1% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses